强生:锐珂捷®埃万妥单抗注射液在中国上市

智通财经
2 hours ago
【强生:锐珂捷®埃万妥单抗注射液在中国上市】9月16日,强生公司宣布,锐珂捷®——埃万妥单抗注射液正式在中国上市,联合利珂®适用于携带表皮生长因子受体19号外显子缺失或21号外显子L858R置换突变的局部晚期或转移性晚期非小细胞肺癌成人患者的一线治疗。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10